Fi3 FINANCIAL ADVISORS, LLC

Position in VRTX — Vertex Pharmaceuticals Inc / Ma

CIK 1862427 INDIANAPOLIS, IN

Position in VRTX

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$280,521

New position

Shares Held

6,625

first reported quarter

Ownership

0.003%

of shares outstanding

% of Portfolio

0.14%

of 13F equity value

Holder Rank

#1,259

of 1,735 holders

Holding Since

Jun 2026

1 quarter on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Fi3 FINANCIAL ADVISORS, LLC holds $696,693 across 4 Biotechnology names. VRTX ranks #2 (40.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INCY	Incyte Corp	2,651	$300,517
2	VRTX	Vertex Pharmaceuticals Inc / Ma This page	6,625	$280,521
3	MESO	Mesoblast Ltd	7,891	$106,765
4	LRMR	Larimar Therapeutics, Inc.	2,915	$8,890

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$280,521	6,625	—	Shares	Sole	2026-08-14
No filing history on record for this holder in this stock.